Addex’s eyelid data fail to make clear case for spasm expansion
Addex’s eyelid data fail to make clear case for spasm [...]
Addex’s eyelid data fail to make clear case for spasm [...]
Iovance sinks 50% as pivotal cell therapy data disappoint investors, [...]
ASCO: Genentech touts bispecific data for DLBCL, calling it ‘groundbreaking’ [...]
Chutes & Ladders—Alchemab CEO resigns immediately citing ‘personal reasons’ mbayer [...]
ASCO: Merck’s Keytruda combo data could spark hope for lymphoma [...]
Avadel’s shares crumble as narcolepsy drug delayed yet again, this [...]
Vertex scoops up Catalyst’s complement pipeline for $60M cash mbayer [...]
With the right partner, Pfizer gains fast-track tag for previously [...]
IN-ACTIV: NRx tanks as peptide fails NIH trial in severe [...]
Forte fields demand to liquidate from top shareholder who says [...]